Why do antivenoms still terrify Brazilian doctors? Lessons from the penicillin treatment decentralization

IF 2.6 4区医学 Q2 PHARMACOLOGY & PHARMACY

Toxicon Pub Date : 2025-04-01 DOI:10.1016/j.toxicon.2025.108329

Wuelton Monteiro , Adele Schwartz Benzaken , Fan Hui Wen

引用次数: 0

Abstract

Penicillin and antivenom treatments may cause early adverse reactions. Given the low incidence of hypersensitivity reactions attributed to penicillin, the Brazilian Ministry of Health determined the decentralization of the use of this medicine to community health centers, especially to treat syphilis and prophylaxis of congenital syphilis. Regarding antivenoms, the establishment of modern purification technologies in the manufacturing process ensured the increasing efficacy and safety in the country. However, lack of training and the use of outdated evidence on the frequency of adverse reactions and the overdiagnosis of hypersensitivity reactions to antivenoms generates resistance from health professionals to administer these products in non-hospital settings. Also, robust studies on the safety of concomitant medications are lacking in this field. This results in delays in treatment leading to poor clinical outcomes.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Toxicon 医学-毒理学

CiteScore

4.80

自引率

10.70%

发文量

358

审稿时长

68 days

期刊介绍： Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee. Toxicon''s "aims and scope" are to publish: -articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms -papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins -molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins -clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained. -material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems. -articles on the translational application of toxins, for example as drugs and insecticides -epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged. -articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon. -review articles on problems related to toxinology. To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.